Questions about Breast Cancer? 1-800-221-2141
 
Do You Have Questions?

1-800-221-2141

Find support 24 hours a day.

Because no one should face breast cancer alone.

Survivor Dorothy
Dorothy - 15-year survivor
"Today’s callers are more knowledgeable. But their emotional needs are still the same. Y-ME is here to provide information, hope, empathy, and sympathy."

Larry Norton, MD

Printer-friendly versionSend to friend

Larry Norton, MD
Deputy Physician –in-Chief for Breast Cancer Programs
Medical Director, Evelyn H. Lauder Breast Center
Norna S. Sarofim Chair in Clinical Oncology
Memorial Sloan-Kettering Cancer Center, New York, NY

Dr. Larry Norton is currently the Deputy Physician in Chief, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, for Breast Cancer Programs, and The Medical Director of MSKCC’s Breast and Imaging Center, which contains the Evelyn H. Lauder Breast Center. He is the founding incumbent of the Norna S. Sarofim Chair of Clinical Oncology at MSKCCand a Professor of Medicine in the Weill Medical College of Cornell University. He received his AB with Highest Distinctionfrom the University of Rochester and his MD from the College of Physicians and surgeons of Columbia University. He trained in medicine and medical research at the Albert Einstein College of Medicine and the National Cancer Institute.

Dr. Norton has dedicated his life to the eradication of cancer by activities in medical care, laboratory and clinical research, advocacy, and government. He was a U.S. Presidential appointee to the National Cancer Advisory Board—the board of directors of the NCI—serving as Chair of the Budget Sub-Committee. A former Director of the American Society of Clinical Oncology, he served as President of ASCO and subsequently Chair of the ASCO Foundation. He has been Vice-Chair of the Lymphoma Committee and a long-serving Chair of the Breast Committee of the Cancer and Leukemia Group B. Dr. Norton is afounder of The Breast Cancer Research Foundation and is currently its Scientific Director. He has served on or chaired numerous committees of the National Cancer Institute, National Institutes of Health, and the Institute of Medicine of the National Academy of Sciences. He is an editorial board member or reviewer for numerous medical journals and on the advisory boards of many advocacy and medical institutions including the Cold Spring Harbor Laboratory Cancer Center and several Specialized Programs of Research Excellence.

Dr. Norton’s personal research has focused on the use of medicines to treat cancer, particularly the application of mathematical methods to optimizing dose and schedule. He has been involved in the development of several effective agents including paclitaxel and trastuzumab. He co-invented the Norton-Simon Model of cancer growth, which has broadly influenced cancer therapy, and more recently the self-seeding concept of cancer metastasis and growth. He is the Principal investigator of an NCI Program Project Grant in Models of Human Breast Cancer and an author of more than 350 published articles and many book chapters.

For his work Dr. Norton has received many honors including election to Phi Beta Kappa and Alpha Omega Alpha and recognition from the M.D. Anderson Cancer Center, the Society for MSKCC, the Italian-American Foundation for Cancer Research, the Don Shula Foundation, SHARE (NY), the Susan G. Komen Foundation, and The Breast Cancer Research Foundation. He received ASCO’s highest honor, the David A. Karnofsky Award, and was a McGuire Lecturer at the San Antonio Breast Cancer Symposium. He has served as a visiting professor throughout the U.S., Canada, South America, Europe, Israel, and Asia and has trained many cancer physicians and researchers.

Breast Cancer News

Breast Cancer feed
Women who receive a type of partial-breast radiation called brachytherapy may have higher rates of breast cancer recurrence and side effects.
Mammograms starting at age 40 may have an acceptable balance of risks and benefits for women with extremely dense breasts or a family history of the...
Although breast cancer-related fatigue is common, it generally runs a self-limiting course and does not persist as long as people had thought;...